P&F Products & Features GmbH is proud to announce that it has received the highly esteemed Houska Prize for outstanding innovation and excellence in the “Research and Development in Small and Medium-Sized Enterprises (SME)” category. This prestigious recognition underscores the company’s commitment to pioneering solutions in structural heart disease treatment, specifically for patients suffering from mitral and tricuspid regurgitation.
The Houska Prize, Austria’s largest privately awarded prize fund for application-driven research, has been granted annually by the B&C Private Foundation since 2005. P&F Products & Features GmbH was honored for its breakthrough work with the TricValve® Transcatheter Bicaval Valve System, designed to treat hemodynamically significant tricuspid insufficiency and caval reflux. The TricValve system is transforming the treatment landscape for patients with severe tricuspid regurgitation, providing a minimally invasive solution where previous methods have often fallen short.
“We are truly honored and thrilled to receive the Houska Prize,” said Prof. Dr. Siegfried Einhellig, President and Co-founder of P&F Products & Features GmbH. “This award reflects the dedication and ingenuity of our exceptional team, who continue to push the boundaries of innovation. The TricValve system exemplifies our commitment to not only advancing medical technology but also improving the lives of patients and supporting healthcare professionals with state-of-the-art tools. We are excited about the future and the continued progress we can make in this critical area of medicine.”
Driving Innovation in Structural Heart Disease Treatment
As a leader in the field of minimally invasive cardiovascular devices, P&F Products & Features GmbH has consistently demonstrated a patient-centered approach, fostering a culture of innovation through its cutting-edge technologies. With a strong focus on research and development, the company has successfully developed a complete infrastructure for manufacturing, distributing, and supporting cardiovascular medical devices worldwide.
The TricValve® Transcatheter heart valve replacement system has already achieved international recognition for its effectiveness, and the Houska Prize adds to a growing list of prestigious awards and honors for the company. P&F Products & Features GmbH continues to set new benchmarks in the medical technology industry, emphasizing the importance of developing and implementing solutions that address the evolving needs of both patients and healthcare providers.
A Global Leader in Cardiovascular Medical Technology
Founded in Vienna, Austria, P&F Products & Features GmbH operates across Europe, North and South America, and other global markets, with its products available in over 70 countries. The company’s commitment to excellence and groundbreaking solutions positions it at the forefront of the medical device industry, particularly in the field of structural heart treatment.
The Houska Prize marks another significant achievement for P&F Products & Features GmbH, a company dedicated to delivering high-quality, innovative solutions to improve patient outcomes. The award highlights the company’s leadership in cardiovascular healthcare and its ability to adapt to changing demands in the medical field.
“We are proud to be recognized for our continued advancements in the field of cardiovascular health, and this recognition motivates us to keep pushing forward with even greater determination,” added Paul Shelton, Director of Clinical Development at P&F USA Inc. “We will continue to invest in research and development and bring novel solutions to the healthcare market.”
For more information about P&F Products & Features GmbH and its award-winning technologies, including the TricValve® system, visit productsandfeatures.com.
About P&F Products & Features GmbH
P&F Products & Features GmbH is a global leader in cardiovascular medical technology, specializing in minimally invasive solutions for mitral and tricuspid regurgitation. With a strong presence in more than 70 countries, the company is committed to developing groundbreaking products that enhance patient outcomes and support healthcare professionals. Headquartered in Vienna, Austria, with operational facilities in Germany, Portugal, Spain, and Brazil, P&F Products & Features GmbH remains at the forefront of innovation in cardiovascular medicine.
CAUTION: The TricValve system is limited by U.S. Federal Law to investigational use. TricValve is CE marked and registered with ANVISA.
###
For more information about P&F Products & Features, contact the company here:
P&F Products & Features
Kaitlyn Parham
3366813007
kaitlynparham@theconnectagency.com
251 Little Falls Drive, 19808 Wilmington, Delaware, USA
